Patients with alopecia were almost entirely able to restore their hair in clinical trials with the new pill

The first drug trials to treat alopecia areata have shown strong results, with 30 to 40% of participants able to regrow almost all of their hair... The company said that a new drug to help alopecia sufferers regrow their hair has been very successful in clinical trials, with 30 up to 40 percent of patients seeing near-full growth.

The Lexington, Massachusetts-based Concert Pharmaceuticals drug is said to help people with alopecia areata. The skin condition, affecting more than 6 million Americans, is the second leading cause of hair loss and can lead to baldness or total hair loss. For some people, this condition only lasts a few months before growing back, while for others, it is permanent.

Concert tested the pill twice daily in a clinical study of 700 people with moderate to severe alopecia areata lost at least half their hair. Of the latter group of subjects, more than half were bald, and generally, no more than 16% of their hair remained. After 24 weeks of testing, 29.6% of those taking the moderate dose of the drug and 41.5% of those taking the high amount had regained at least 80% of their hair.

Concert CEO Roger Tung told the Boston Globe that the results were "some of the best data" yet seen on potential treatments for alopecia.

"Like many other autoimmune diseases, this one didn't get much attention until relatively recently," Tung said, adding that he's met many people with the disease over the past few months and found that it "destroys people's lives." -people. can."